Natural bioactive compounds-doxorubicin combinations targeting topoisomerase II-alpha: Anticancer efficacy and safety

A Elfadadny, RF Ragab, R Hamada… - Toxicology and Applied …, 2023 - Elsevier
Cancer is one of the leading causes of death worldwide, so pursuing effective and safe
therapeutics for cancer is a key research objective nowadays. Doxorubicin (DOX) is one of …

Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases

M Alam, S Ahmed, M Abid, GM Hasan… - Journal of Cellular …, 2023 - Wiley Online Library
Microtubule affinity‐regulating kinase 4 (MARK4) is a member of the Ser/Thr protein kinase
family, phosphorylates the microtubule‐connected proteins and plays a vital role in causing …

Anticancer and antibacterial activities of embelin: Micro and nano aspects

M Alavi, F Martinez, DR Delgado… - Micro Nano Bio …, 2022 - mnba-journal.com
There are some reported anticancer and antibacterial effects for embelin, although, it's poor
aqueous solubility and bioavailability are main hindrance to apply embelin in therapeutics …

[HTML][HTML] In silico investigations identified Butyl Xanalterate to competently target CK2α (CSNK2A1) for therapy of chronic lymphocytic leukemia

SA Alsagaby, D Iqbal, I Ahmad, H Patel, SA Mir… - Scientific reports, 2022 - nature.com
Chronic lymphocytic leukemia (CLL) is an incurable malignancy of B-cells. In this study,
bioinformatics analyses were conducted to identify possible pathogenic roles of CK2α …

Investigating MARK4 inhibitory potential of Bacopaside II: targeting Alzheimer's disease

S Anwar, T Mohammad, MK Azhar, H Fatima… - International journal of …, 2023 - Elsevier
Microtubule affinity regulating kinase 4 (MARK4) is known to hyperphosphorylate tau
protein, which subsequently causes Alzheimer's disease (AD). MARK4 is a well-validated …

Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach

BS Alotaibi, J Joshi, MR Hasan, MS Khan… - Journal of …, 2023 - Taylor & Francis
Rho-associated protein kinase 1 (ROCK1) is a member of the AGC family which plays
crucial roles in inflammatory diseases and cancer progression. Elevated expression of …

Exploring the potential of baicalin and resveratrol as PIM-1 kinase inhibitors: Therapeutic targeting of prostate and breast cancers

A Rathi, A Khan, S Haider, S Roy, A Taiyab… - Journal of Molecular …, 2024 - Elsevier
PIM-1 kinase is a member of the Ser/Thr kinases family, a well-studied therapeutic target for
cancer therapy. The overexpression of PIM-1 is associated with prostate and breast cancer …

Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches

T Ali, F Anjum, A Choudhury, A Shafie… - Journal of …, 2024 - Taylor & Francis
Spleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase that plays an essential role in
signal transduction across different cell types. In the context of allergy and autoimmune …

[HTML][HTML] Identifying potential inhibitors of phosphatidylinositol 4, 5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism

T Mohammad, A Hussain, MF Alajmi, S Hasan… - Chemical Physics …, 2024 - Elsevier
Abstract Phosphatidylinositol 4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA)
plays a crucial role in signaling pathways and has emerged as an attractive target for …

Identification of selective plant-derived natural carotenoid and flavonoids as the potential inhibitors of DHHC-mediated protein S-palmitoylation: an in silico study

S Chaturvedi, N Pandya, S Sadhukhan… - Journal of …, 2024 - Taylor & Francis
Protein S-palmitoylation mediated by DHHCs is recognized as a distinct and reversible form
of lipid modification connected with several health perturbations, including …